Clinical investigations for SUS, the Brazilian public health system

Sao Paulo Medical Journal

Ana Patrícia De Paula²  Silvana Pereira Giozza¹  Michelle Zanon Pereira¹  Patrícia Souza Boaventura¹  Leonor Maria Pacheco Santos¹  Camile Giaretta Sachetti¹  César Omar Carranza Tamayo¹  Clarissa Campos Guaragna Kowalski¹  Flavia Tavares Silva Elias¹  Suzanne Jacob Serruya¹  Reinaldo Guimarães¹ 

[1] ,Fundação de Ensino e Pesquisa em Ciências da Saúde Escola Superior de Ciências da Saúde Brasília Federal District ,Brazil

关键词: Biomedical research;    Technology assessment;    biomedical;    Health policy;    Health services research;    Public health;    Pesquisa biomédica;    Avaliação da tecnologia biomédica;    Política de saúde;    Pesquisa sobre serviços de saúde;    Saúde pública;   

DOI  :  10.1590/S1516-31802012000300008

来源: SciELO

【 摘 要 】

CONTEXT AND OBJECTIVE: Scientific and technological development is crucial for advancing the Brazilian health system and for promoting quality of life. The way in which the Brazilian Ministry of Health has supported clinical research to provide autonomy, self-sufficiency, competitiveness and innovation for the healthcare industrial production complex, in accordance with the National Policy on Science, Technology and Innovation in Healthcare, was analyzed. DESIGN AND SETTING: Descriptive investigation, based on secondary data, conducted at the Department of Science and Technology, Ministry of Health. METHODS: The Ministry of Health's research management database, PesquisaSaúde, was analyzed from 2002 to 2009, using the key word "clinical research" in the fields "primary sub-agenda" or "secondary sub-agenda". The 368 projects retrieved were sorted into six categories: basic biomedical research, preclinical studies, expanded clinical research, clinical trials, infrastructure support and health technology assessment. From a structured review on "clinical research funding", results from selected countries are presented and discussed. RESULTS: The amount invested was R$ 140 million. The largest number of projects supported "basic biomedical research", while the highest amounts invested were in "clinical trials" and "infrastructure support". The southeastern region had the greatest proportion of projects and financial resources. In some respects, Brazil is ahead of other BRICS countries (Russia, India, China and South Africa), especially with regard to establishing a National Clinical Research Network. CONCLUSION: The Ministry of Health ensured investments to encourage clinical research in Brazil and contributed towards promoting cohesion between investigators, health policies and the healthcare industrial production complex.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License